Complement Decay-Accelerating Factor (CD55) Antibody (HRP)

Product specifications

Primary Antibodies

Complement Decay-Accelerating Factor (CD55)

Rabbit

Human

Optimal dilutions/concentrations should be determined by the end user.

Polyclonal

HRP

IgG

> 95%

Purified by Protein G.

20 µg

50 µg

100 µg

200 µg

1 mg

Liquid

ELISA

0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.

Shipped within 5-10 working days.

Aliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.

No

P08174

1604

Cromer blood group,CR,TC,DAF,CROM,CHAPLE,Complement decay-accelerating factor

Antibody anti-CD55

RUO

Concentration: 0.42 mg/ml - 

Descripción

CD55, also known as decay-accelerating factor (DAF), is a glycoprotein that plays a critical role in regulating the complement system, a part of the innate immune response. The primary function of CD55 is to protect host cells from complement-mediated damage by inhibiting the formation of C3 and C5 convertases, key enzymes in the complement activation pathways. CD55 is widely expressed on the surface of many cell types, including erythrocytes, leukocytes, endothelial cells, and epithelial cells. Its expression is essential for preventing unintended complement activation on host tissues, which could lead to cell lysis and tissue damage. CD55 is particularly important in safeguarding cells from the alternative pathway and classical pathway of complement activation. The complement system is a major defense mechanism that helps the body clear pathogens through opsonization, inflammation, and lysis of infected or foreign cells. By regulating this system, CD55 ensures that the complement system does not damage self-cells, thus maintaining tissue integrity during immune responses.

Related Products

Human CD55 (Complement decay-acceleRating factor) ELISA Kit

Ver Producto

Mouse CD55 (Complement decay-acceleRating factor) ELISA Kit

Ver Producto

CD55 antibody

This gene encodes a glycoprotein involved in the regulation of the complement cascade. Binding of the encoded protein to complement proteins accelerates their decay, thereby disrupting the cascade and preventing damage to host cells. Antigens present on this protein constitute the Cromer blood group system (CROM). Alternative splicing results in multiple transcript variants. The predominant transcript variant encodes a membrane-bound protein, but alternatively spliced transcripts may produce soluble proteins.

Ver Producto